Proteomics

Dataset Information

0

A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells


ABSTRACT: In a previous study, we described the biochemical properties of a newly synthesized group of imidazopyrazole compounds. In this paper, to improve our knowledge on the pharmacological properties of these chemical compounds, we carry out a differential proteomic analysis on a hu-man melanoma cell line treated with one of these imidazopyrazole derivatives. The results show the changes to Skmel28 melanoma cell line proteome induced by 24h, 48h and 72h of imidazopy-razole treatment.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Melanocyte, Skin

DISEASE(S): Skin Cancer

SUBMITTER: Gabriela Coronel Vargas  

LAB HEAD: Camillo Rosano

PROVIDER: PXD049299 | Pride | 2024-06-21

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
2024_07_02_sp_CB556_only_30102023_DEPOSITED_Proteins_List.txt Txt
Sample_table.txt Txt
checksum.txt Txt
sample10a_30102023.msf Msf
sample10a_30102023.raw Raw
Items per page:
1 - 5 of 51

Similar Datasets

2023-05-23 | PXD037657 | Pride
2024-01-20 | PXD037653 | Pride
2025-03-03 | PXD040214 | Pride
2022-04-30 | E-MTAB-9701 | biostudies-arrayexpress
2021-09-09 | PXD022351 | Pride
2023-08-30 | PXD014150 | Pride
2014-12-15 | E-GEOD-61043 | biostudies-arrayexpress
2019-06-01 | E-MTAB-7751 | biostudies-arrayexpress
2024-10-30 | E-MTAB-13909 | biostudies-arrayexpress
2020-12-18 | E-MTAB-9924 | biostudies-arrayexpress